C4 Therapeutics, Inc. (CCCC) vs TRex Bio Inc. (TRXB)

C4 Therapeutics, Inc. CCCC 3.12 +5.76%
TRex Bio Inc. TRXB 13.26 +2.08%

C4 Therapeutics, Inc. and TRex Bio Inc. are both Biotechnology companies. C4 Therapeutics, Inc. and TRex Bio Inc. are of similar size ($362.9M and $356.5M).

Metric	CCCC	TRXB	Biotechnology median
P/E	n/m	—	10.60
P/S	13.15	—	9.40
P/B	1.86	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	7.38	—	9.02
Earnings yield	(23.08%)	—	(32.88%)
Free cash flow yield	(18.88%)	—	(23.13%)

Metric	CCCC	TRXB	Biotechnology median
Gross margin	100.00%	—	68.51%
Operating margin	(315.86%)	—	0.00%
Net margin	(282.22%)	—	0.00%
Free cash flow margin	(246.71%)	—	0.00%
Return on equity	(47.62%)	—	(51.96%)
Return on assets	(30.50%)	—	(46.06%)
Return on invested capital	(279.99%)	—	0.00%

Metric	CCCC	TRXB	Biotechnology median
Revenue growth (TTM)	7.20%	—	6.76%
EPS growth (last fiscal year)	16.45%	—	29.88%
Revenue growth, 5-year CAGR	1.61%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CCCC	TRXB	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	5.17	—	4.97
Net debt to EBITDA	2.14	—	1.01

Metric	CCCC	TRXB	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	CCCC	TRXB	Biotechnology median
Market cap	362.93m	356.52m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack